Novel methods of treating hearing loss
US-2024390323-A1 · Nov 28, 2024 · US
US11478550B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11478550-B2 |
| Application number | US-201816198556-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 21, 2018 |
| Priority date | Nov 21, 2018 |
| Publication date | Oct 25, 2022 |
| Grant date | Oct 25, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The subject matter of this invention relates to hydrogel compositions and, more particularly, to hydrogel compositions comprising block copolymers (BCPs) capable of self-assembly into nanoparticles for the delivery and controlled release of therapeutic cargos.
Opening claim text (preview).
What is claimed is: 1. A hydrogel composition comprising: a first ABA triblock copolymer having negatively charged A blocks, wherein the first ABA triblock copolymer is a phenylboronic acid-functionalized polycarbonate/poly(ethylene glycol) (PEG) ABA triblock copolymer; and a second ABA triblock copolymer having positively charged A blocks. 2. The hydrogel composition of claim 1 , wherein the first ABA triblock copolymer has the structure of formula I: wherein m is between 1 and 10 and PEG 10K is 10 kDa poly(ethylene glycol). 3. The hydrogel composition of claim 2 , wherein m is 5. 4. The hydrogel composition of claim 1 , wherein the second ABA triblock copolymer includes A blocks containing either guanidine or thiouronium. 5. The hydrogel composition of claim 4 , wherein the second ABA triblock copolymer has the structure of formula II: wherein x is between 1 and 10, n is 227, and TFA is trifluoroacetic acid. 6. The hydrogel composition of claim 5 , wherein x is 5. 7. The hydrogel composition of claim 4 , wherein the second ABA triblock copolymer has the structure of formula III: wherein m is between 1 and 10 and n is 227. 8. The hydrogel composition of claim 7 , wherein m is 5. 9. A micellar particle comprising: a hydrogel composition comprising: a first ABA triblock copolymer having negatively charged A blocks, wherein the first ABA triblock copolymer is a phenylboronic acid-functionalized polycarbonate/poly(ethylene glycol) (PEG) ABA triblock copolymer; and a second ABA triblock copolymer having positively charged A blocks; and at least one agent for delivery within the hydrogel composition. 10. The micellar particle of claim 9 , wherein: the first ABA triblock copolymer is a phenylboronic acid-functionalized polycarbonate/poly(ethylene glycol) (PEG) ABA triblock copolymer has the structure of formula I: wherein m is between 1 and 10 and PEG 10K is 10 kDa poly(ethylene glycol); and the second ABA triblock copolymer has the structure of formula II or the structure of formula III: wherein x is between 1 and 10, n is 227, and TFA is trifluoroacetic acid, wherein m is between 1 and 10 and n is 227.
for biomedical use · CPC title
Compositions of polycarbonates; Compositions of derivatives of polycarbonates · CPC title
Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)} · CPC title
containing two or more polymers of the same hierarchy C08L, and differing only in parameters such as density, comonomer content, molecular weight, structure · CPC title
Preparation of gels · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.